SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-060475
Filing Date
2016-04-06
Accepted
2016-04-06 19:58:43
Documents
2
Period of Report
2016-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 8094
2 poa_rowlinson.htm EX-24 6218
  Complete submission text file 0001140361-16-060475.txt   15753
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
Rowlinson Scott W (Reporting) CIK: 0001655979 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 161558624